ABEONA THERAPEUTICS INC. (ABEO)
Data as of , from SEC Form 4 filings.
Net insider selling (90d)Watch ABEO
See up to 3 months of ABEO. The 7-day demo opens the 1M and 3M ranges and puts ABEO on your watchlist.
Start 7-day demoLatest ABEO insider trades
Vishwas Seshadri - OfficerOpen-market sale$101K
About ABEONA THERAPEUTICS INC. (ABEO)
The SEC lists ABEONA THERAPEUTICS INC. under CIK 0000318306, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
ABEO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 6 | 56,906 | $306K |
ABEO insider transactions (Form 4)
3263 Form 4 filings on record, the earliest from Oct 17, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Bernhardt G. Zeiher - Director | Grant or award | Common Stock | 37,313 footnote F1 | $0.00 | - | |
| ||||||
| Eric Crombez - Director | Grant or award | Common Stock | 37,313 footnote F1 | $0.00 | - | |
| ||||||
| Christine Berni Silverstein - Director | Grant or award | Common Stock | 37,313 footnote F1 | $0.00 | - | |
| ||||||
| Michael Amoroso - Director | Grant or award | Common Stock | 37,313 footnote F1 | $0.00 | - | |
| ||||||
| Faith L. Charles - Director | Grant or award | Common Stock | 37,313 footnote F1 | $0.00 | - | |
| ||||||
| Mark Alvino - Director | Grant or award | Common Stock | 37,313 footnote F1 | $0.00 | - | |
| ||||||
| Leila Alland - Director | Grant or award | Common Stock | 37,313 footnote F1 | $0.00 | - | |
| ||||||
| Madhav Vasanthavada - Officer | Grant or award | Common Stock | 76,621 footnote F1 | $0.00 | - | |
| Madhav Vasanthavada - Officer | Open-market sale | Common Stock | 12,610 | $5.29 footnote F3 | $67K | |
| ||||||
 Joseph Walter Vazzano - Officer | Open-market sale | Common Stock | 18,666 | $5.33 footnote F2 | $100K | |
| ||||||
| Vishwas Seshadri - Officer | Open-market sale | Common Stock | 69,832 | $5.33 footnote F2 | $372K | |
| ||||||
| Brendan M. O'Malley - Officer | Open-market sale | Common Stock | 13,578 | $5.33 footnote F2 | $72K | |
| ||||||
| Mark Alvino - Director | Open-market sale | Common Stock | 13,500 | $5.23 footnote F1 | $71K | |
| ||||||
| Joseph Walter Vazzano - Officer | Grant or award | Common Stock | 133,595 footnote F1 | $0.00 | - | |
| ||||||
| Vishwas Seshadri - Officer | Grant or award | Common Stock | 365,422 footnote F1 | $0.00 | - | |
| ||||||
| Brendan M. O'Malley - Officer | Grant or award | Common Stock | 113,949 footnote F1 | $0.00 | - | |
| ||||||
| Vishwas Seshadri - Officer | Open-market sale | Common Stock | 25,000 | $5.31 footnote F2 | $133K | |
| ||||||
| Mark Alvino - Director | Open-market sale | Common Stock | 15,000 | $4.74 footnote F1 | $71K | |
| ||||||
| Vishwas Seshadri - Officer | Open-market sale | Common Stock | 249 | $5.49 | $1K | |
| Brendan M. O'Malley - Officer | Open-market sale | Common Stock | 9,366 | $5.39 | $51K | |
| Vishwas Seshadri - Officer | Open-market sale | Common Stock | 19,274 | $5.39 | $104K | |
| Vishwas Seshadri - Officer | Open-market sale | Common Stock | 25,000 | $5.24 | $131K | |
| Joseph Walter Vazzano - Officer | Open-market sale | Common Stock | 9,035 | $5.39 | $49K | |
| Brendan M. O'Malley - Officer | Open-market sale | Common Stock | 688 | $5.43 | $4K | |
| Joseph Walter Vazzano - Officer | Open-market sale | Common Stock | 15,000 | $7.36 | $110K | |
| Eric Crombez - Director | Open-market sale | Common Stock | 4,718 | $6.93 | $33K | |
| Joseph Walter Vazzano - Officer | Open-market sale | Common Stock | 1,502 | $6.64 | $10K | |
| Brendan M. O'Malley - Officer | Open-market sale | Common Stock | 17,428 | $5.86 | $102K | |
| Vishwas Seshadri - Officer | Open-market sale | Common Stock | 69,420 | $5.86 | $407K | |
| Faith L. Charles - Director | Open-market sale | Common Stock | 10,738 | $5.86 | $63K | |
| Christine Berni Silverstein - Director | Open-market sale | Common Stock | 13,093 | $5.86 | $77K | |
| Joseph Walter Vazzano - Officer | Open-market sale | Common Stock | 25,411 | $5.86 | $149K | |
Item 7.01, 9.01
Item 2.02, 9.01
Item 5.07
Item 5.02
Recent ABEO Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Vazzano Joseph Walter | Officer | 9,191 | $47K | View on EDGAR | |
| Seshadri Vishwas | Officer | 19,608 |
ABEO insider trading FAQ
What is the latest insider trade for ABEO?
ABEONA THERAPEUTICS INC. (ABEO) had 6 insider filings in the last 90 days, with the most recent on 2026-09-30. The full record for ABEO runs to 63 Form 4 filings, the earliest from 2024-10-17. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ABEO stock?
No insider purchases of ABEO were filed in the last 90 days.
How many insiders are selling ABEO stock?
6 insider sales of ABEO were filed in the last 90 days, totaling $306K.
Where can I see ABEO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ABEO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Vishwas Seshadri view on EDGAR
- - Joseph Walter Vazzano view on EDGAR
- - Brendan M. O'Malley view on EDGAR
- - Madhav Vasanthavada view on EDGAR
- - Mark Alvino view on EDGAR
- - Joseph Walter Vazzano view on EDGAR
- - Joseph Walter Vazzano view on EDGAR
- - Vishwas Seshadri view on EDGAR
- - Brendan M. O'Malley view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where ABEO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ABEO with a 7-day demo
- ABEO on your watchlist
- Every ABEO Form 4 filing on record
- Up to 3 months of ABEO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
